Literature DB >> 27686599

Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturation.

Christina Vrahnas1, Thomas A Pearson1, Athena R Brunt2, Mark R Forwood2, Keith R Bambery3, Mark J Tobin3, T John Martin1, Natalie A Sims4.   

Abstract

Intermittent administration of parathyroid hormone (PTH) is used to stimulate bone formation in patients with osteoporosis. A reduction in the degree of matrix mineralisation has been reported during treatment, which may reflect either production of undermineralised matrix or a greater proportion of new matrix within the bone samples assessed. To explore these alternatives, high resolution synchrotron-based Fourier Transform Infrared Microspectroscopy (sFTIRM) coupled with calcein labelling was used in a region of non-remodelling cortical bone to determine bone composition during anabolic PTH treatment compared with region-matched samples from controls. 8week old male C57BL/6 mice were treated with vehicle or 50μg/kg PTH, 5 times/week for 4weeks (n=7-9/group). Histomorphometry confirmed greater trabecular and periosteal bone formation and 3-point bending tests confirmed greater femoral strength in PTH-treated mice. Dual calcein labels were used to match bone regions by time-since-mineralisation (bone age) and composition was measured by sFTIRM in six 15μm2 regions at increasing depth perpendicular to the most immature bone on the medial periosteal edge; this allowed in situ measurement of progressive changes in bone matrix during its maturation. The sFTIRM method was validated in vehicle-treated bones where the expected progressive increases in mineral:matrix ratio and collagen crosslink type ratio were detected with increasing bone maturity. We also observed a gradual increase in carbonate content that strongly correlated with an increase in longitudinal stretch of the collagen triple helix (amide I:amide II ratio). PTH treatment did not alter the progressive changes in any of these parameters from the periosteal edge through to the more mature bone. These data provide new information about how the bone matrix matures in situ and confirm that bone deposited during PTH treatment undergoes normal collagen maturation and normal mineral accrual.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27686599     DOI: 10.1016/j.bone.2016.09.022

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

Review 1.  Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown.

Authors:  Martha Blank; Natalie A Sims
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

2.  The effect of carbamazepine on bone structure and strength in control and osteogenesis imperfecta (Col1a2 +/p.G610C ) mice.

Authors:  Martha Blank; Narelle E McGregor; Lynn Rowley; Louise H W Kung; Blessing Crimeen-Irwin; Ingrid J Poulton; Emma C Walker; Jonathan H Gooi; Shireen R Lamandé; Natalie A Sims; John F Bateman
Journal:  J Cell Mol Med       Date:  2022-06-14       Impact factor: 5.295

Review 3.  Cortical bone development, maintenance and porosity: genetic alterations in humans and mice influencing chondrocytes, osteoclasts, osteoblasts and osteocytes.

Authors:  Tsuyoshi Isojima; Natalie A Sims
Journal:  Cell Mol Life Sci       Date:  2021-07-01       Impact factor: 9.261

4.  The Effect of Ethanol Consumption on Composition and Morphology of Femur Cortical Bone in Wild-Type and ALDH2*2-Homozygous Mice.

Authors:  Andrey V Malkovskiy; Lauren D Van Wassenhove; Yury Goltsev; Kwame Osei-Sarfo; Che-Hong Chen; Bradley Efron; Lorraine J Gudas; Daria Mochly-Rosen; Jayakumar Rajadas
Journal:  Calcif Tissue Int       Date:  2020-10-17       Impact factor: 4.333

5.  Increased autophagy in EphrinB2-deficient osteocytes is associated with elevated secondary mineralization and brittle bone.

Authors:  Christina Vrahnas; Martha Blank; Toby A Dite; Liliana Tatarczuch; Niloufar Ansari; Blessing Crimeen-Irwin; Huynh Nguyen; Mark R Forwood; Yifang Hu; Mika Ikegame; Keith R Bambery; Cyril Petibois; Eleanor J Mackie; Mark J Tobin; Gordon K Smyth; Jonathan S Oakhill; T John Martin; Natalie A Sims
Journal:  Nat Commun       Date:  2019-07-31       Impact factor: 14.919

6.  The Transcription Factor Foxc1 Promotes Osteogenesis by Directly Regulating Runx2 in Response of Intermittent Parathyroid Hormone (1-34) Treatment.

Authors:  Ningjuan Ouyang; Hongliang Li; Minjiao Wang; Hongzhou Shen; Jiawen Si; Guofang Shen
Journal:  Front Pharmacol       Date:  2020-05-05       Impact factor: 5.810

7.  Bone loss markers in the earliest Pacific Islanders.

Authors:  Justyna J Miszkiewicz; Frédérique Valentin; Christina Vrahnas; Natalie A Sims; Jitraporn Vongsvivut; Mark J Tobin; Geoffrey Clark
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.